Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats

Journal of Cerebral Blood Flow and Metabolism

Volumn 16, Issue 5, 1996, Pages 1014-1025

  Bassant, M H ^a   Jazat Poindessous, F ^a   Lamour, Y ^a  

^a INSERM   (France)

Author keywords

Acetylcholine; Aging; Cerebral glucose utilization; Dichlorvos; Metrifonate

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; DEOXYGLUCOSE; DICHLORVOS; GLUCOSE; METRIFONATE; PHYSOSTIGMINE; TACRINE;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN METABOLISM; CONTROLLED STUDY; ENZYME INHIBITION; GLUCOSE BRAIN LEVEL; GLUCOSE UTILIZATION; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029744529     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199609000-00027     Document Type: Article

References (22)

1. Araujo DA, Lapchak PA, Meaney MJ, Collier B, Quirion R (1990) Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites. J Neurosci 10:3069-3078
2. Bassant MH, Jazat F, Lamour Y (1993) Tetrahydroaminoacridine and physostigmine increase cerebral glucose utilization in specific cortical and subcortical regions in the rat. J Cereb Blood Flow Metab 13:855-864
3. Bassant MH, Jazat FR, Lamour YA (1994) Age-related alterations in local cerebral glucose utilization in the Sprague-Dawley rat. Neurodegeneration 3:243-250
4. Bassant MH, Poindessous-Jazat F, Lamour Y (1995) Metabolic response to tacrine (THA) and physostigmine in the aged rat brain. J Cereb Blood Flow Metab 15:1093-1102
5. Becker RE (1991) Therapy of the cognitive deficit in Alzheimer's disease: the cholinergic system. In: Cholinergic Basis for Alzheimer Therapy (Becker R, Giacobini E, eds), Boston, Birhauser, pp 1-22
6. Becker RE, Giacobini E (1988) Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: clinical, pharmacological, and therapeutic aspects. Drug Dev Res 12:163-195
7. Becker RE, Colliver J, Elble R, Feldman E, Giacobini E, Kumar V, Markwell S, Moriearty P, Parks R, Shillcutt SD, Unni L, Vicari S, Womack C, Zec RF (1990) Effects of metrifonate, a long-acting cholinesterase inhibitor, in Alzheimer disease: report of an open trial. Drug Dev Res 19:425-434
8. 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 40:711-714
9. Biegon A, Hanau M, Greenberger V, Segal M (1989) Aging and brain cholinergic muscarinic receptor subtypes: an autoradiographic study in the rat. Nenrobiol Aging 10:305-310
10. Bueding E, Liu CL, Rogers SH (1972) Inhibition by metrifonate and dichlorvos of cholinesterases in schistosomes. Br J Pharmacol 46:480-487
11. de Bilbao F, Jazat F, Lamour Y, Senut MC (1991) Age-related changes in galanin-immunoreactive cells of the rat medial septal area. J Comp Neurol 313:613-624
12. Decker MW (1987) The effect of aging on hippocampal and cortical projections of the forebrain cholinergic system. Brain Res Rev 12:423-438
13. de Leon MJ, Ferris SH, George AE, Christman DR, Fowler JS, Gentes C, Reisberg B, Gee B, Emmerich M, Yonekura Y, Brodle J, Kricheff II, Wolf AP (1983) Positron emission tomography studies of aging and Alzheimer's disease. Am J Neuroradiol 4:568-571
14. Fisher W, Gage FH, Björklord A (1989) Degenerative changes in forebrain nuclei correlate with cognitive impairments in aged rats. Enr J Neurosci 1:34-45
15. Foster ML, Chase TH, Mansi L, Brooks R, Fedio P, Patronas NJ, Di Chiro G (1984) Cortical abnormalities in Alzheimer's disease. Ann Neurol 6:649-654
16. Giacobini E (1991) The second generation of cholinesterase inhibitors: pharmacological aspects. In: Cholinergic Basis for Alzheimer Therapy (Becker R, Giacobini E, eds), Boston, Birhaüser, pp 247-262
17. Goldsmith M, Van Der Kooy D (1988) Separate non-cholinergic descending projections and ascending projections from the nucleus tegmenti pedunculopontinus. Brain Res 445:386-391
18. Hallack M, Giacobini E (1987) A comparison of the effects of two inhibitors on brain cholinesterase. Neurapharmacology 26:521-530
19. Hallack M, Giacobini E (1989) Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain. Neurapharmacalogy 28:199-206
20. Horwitz B, Duara R, Rapoport SI (1986) Age differences in intercorrelations between regional cerebral metabolic rates for glucose. Ann Neurol 19:60-67
21. Hösli E, Hösli L (1988) Autoradiographic localization of binding sites for muscarinic and nicotinic agonists and antagonists on cultured astrocytes. Exp Brain Res 71:450-454
22. Kuhl DE, Metter EJ, Riege WH, Hawkins RA (1984) The effect of normal aging on patterns of local cerebral glucose utilization. Ann Neurol 15:S133-S137